Connective Capital Management, LLC
Position in PCSA — Processa Pharmaceuticals, Inc.
CIK 1543568
PALO ALTO, CA
Position in PCSA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$163,726
-$14,882 QoQ
Shares Held
85,274
+20.6% QoQ
Ownership
3.05%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1
of 12 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCSA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connective Capital Management, LLC holds $959,269 across 6 Biotechnology names. PCSA ranks #4 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PYPD |
PolyPid Ltd.
|
67,600 | $343,408 | |
| 2 | NNVC |
Nanoviricides, Inc.
|
185,217 | $255,599 | |
| 3 | ONCY |
Oncolytics Biotech Inc
|
185,712 | $176,426 | |
| 4 | PCSA |
Processa Pharmaceuticals, Inc.
This page
|
85,274 | $163,726 | |
| 5 | HCWB |
HCW Biologics Inc.
|
3,338 | $16,656 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
1,016 | $3,454 |
All Filings in PCSA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $163,726 | 85,274 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $178,608 | 70,736 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||